Compare Moderna, Inc. (MRNA) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Open Text Corporation — how do they compare? Moderna, Inc. trades at $63.62 (market cap $24.18B), while Open Text Corporation trades at $23.97 (market cap $5.80B). The key difference: Moderna, Inc. is far larger — about 4.2× Open Text Corporation's market cap, and Open Text Corporation pays a 4.67% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | OTEX | |
|---|---|---|
Market Cap | $24.18B | $5.80B |
Sector | Health | Technology |
52-Week High | $81.80 | $39.69 |
52-Week Low | $22.36 | $20.01 |
Enterprise Value | $20.33B | $10.81B |
Dividend Yield | — | 4.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.
The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.
Open Text Corporation (OTEX) trades at $23.95, down 3.11% over the past day. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company shows strong profitability with a 73.74% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights Q4 2026 results with cloud revenue growth and strategic investments in AI.
The investment outlook is positive given attractive valuations like a P/E of 9.29 and a consensus price target of $29.33 implying significant upside. Key risks include execution of growth initiatives and competitive pressures in the software sector. Analyst sentiment is mixed but leans cautious with a majority hold rating.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
